Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Albinism, Ocular”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT01377077
What this trial is testing

Punchgrafting Techniques for Vitiligo

Who this might be right for
Non-segmental VitiligoSegmental VitiligoPiebaldism
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 35
Early research (Phase 1)Looking for participantsNCT06805825
What this trial is testing

The c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Who this might be right for
Gastrointestinal Stromal TumorsSmall-cell Lung CancerAdenoid Cystic Carcinoma+4 more
Novelty Nobility, Inc. 67
Not applicableStudy completedNCT00808106
What this trial is testing

Clinical, Cellular, and Molecular Investigation Into Oculocutaneous Albinism

Who this might be right for
Oculocutaneous Albinism
National Human Genome Research Institute (NHGRI) 206
Not applicableUnknownNCT00006056
What this trial is testing

Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders

Who this might be right for
Chediak-Higashi SyndromeGraft Versus Host DiseaseX-Linked Lymphoproliferative Syndrome+3 more
Fairview University Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT02272998
What this trial is testing

Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.

Who this might be right for
Malignant Neoplasm
Sameek Roychowdhury 22
Early research (Phase 1)Study completedNCT01917708
What this trial is testing

Bone Marrow Transplant With Abatacept for Non-Malignant Diseases

Who this might be right for
Hurler SyndromeFanconi AnemiaGlanzmann Thrombasthenia+12 more
Emory University 10
Not applicableActive Not RecruitingNCT00084305
What this trial is testing

Analysis of Specimens From Individuals With Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisHealthy VolunteersHermansky-Pudlak Syndrome (HPS)
National Human Genome Research Institute (NHGRI) 315
Not applicableActive Not RecruitingNCT01652092
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies

Who this might be right for
SCIDOmenn's SyndromeReticular Dysgenesis+11 more
Masonic Cancer Center, University of Minnesota 57
Post-approval studies (Phase 4)UnknownNCT01640678
What this trial is testing

Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients

Who this might be right for
PiebaldismSegmental Vitiligo
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 10
Large-scale testing (Phase 3)Ended earlyNCT00176826
What this trial is testing

T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders

Who this might be right for
Hemophagocytic LymphohistiocytosisX-Linked Lymphoproliferative DisordersChediak-Higashi Syndrome+4 more
Masonic Cancer Center, University of Minnesota 22
Testing effectiveness (Phase 2)Ended earlyNCT01663935
What this trial is testing

Vision Response to Dopamine Replacement

Who this might be right for
AlbinismOculocutaneous Albinism
University of Wisconsin, Madison 20
Not applicableStudy completedNCT00005933
What this trial is testing

Learning and Behavior Problems in Children With Chronic Granulomatous Disease and Related Disorders

Who this might be right for
Chediak Higashi SyndromeChronic Granulomatous DiseaseJob's Syndrome+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 150
Not applicableStudy completedNCT05455580
What this trial is testing

Nurses Taking On Readiness Measures - Mercer County, New Jersey

Who this might be right for
DisasterVulnerable Populations
Hunter College of City University of New York 31
Not applicableEnded earlyNCT01319851
What this trial is testing

Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
ThalassemiaSickle Cell DiseaseGlanzmann Thrombasthenia+10 more
Emory University 3
Not applicableLooking for participantsNCT04528355
What this trial is testing

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+2 more
Paul Szabolcs 50
Large-scale testing (Phase 3)UnknownNCT04333108
What this trial is testing

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment

Who this might be right for
Indolent Systemic Mastocytosis
AB Science 140
Testing effectiveness (Phase 2)Study completedNCT01838655
What this trial is testing

Nitisinone for Type 1B Oculocutaneous Albinism

Who this might be right for
AlbinismVision Loss
National Eye Institute (NEI) 5
Not applicableStudy completedNCT03959605
What this trial is testing

Genetic Determinant of Foveolar Hypoplasia in Parents of Albinos Children

Who this might be right for
Albinism, Ocular
Fondation Ophtalmologique Adolphe de Rothschild 48
Not applicableLooking for participantsNCT00001456
What this trial is testing

Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome

Who this might be right for
Hermansky-Pudlak Syndrome (HPS)
National Human Genome Research Institute (NHGRI) 600
Testing effectiveness (Phase 2)Study completedNCT01126814
What this trial is testing

Imatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid Leukemia

Who this might be right for
Leukemia
University Health Network, Toronto 35
Next Page